Literature DB >> 32069127

Psychometric properties of Persian version of the Barkley deficits in executive functioning scale-children and adolescents.

Ali Mashhadi1, Zahra Hosseinzadeh Maleki2, Jafar Hasani3, Seyyed Kazem Rasoolzadeh Tabatabaei1.   

Abstract

The Barkley Deficits in Executive Functioning Scale-Children and Adolescents (BDEFS-CA) is an empirically based tool for evaluating clinically significant dimensions of child and adolescent executive functioning. The present study examined the psychometric properties of Persian version of the BDEFS-CA Long Form parent-report in children and adolescents aged 6-18 years old (n = 2,295, 51% girls). The results of confirmatory factor analysis (CFA) consistently underscored a five-factor structure (self-management to time, self-organization/problem solving, self-restraint, self-motivation and self-regulation of emotion), resembling the original factor structure, in Persian language. Additionally, Results showed that Persian version of the BDEFS-CA Long Form demonstrated high internal consistency and test-retest reliabilities. Convergent validity with Childhood Executive Functioning Inventory (CHEXI) and divergent validity between normal and clinical groups were good. Overall, findings provide support for the validity and reliability Persian version of the BDEFS-CA Long Form, which can be used to assess executive dysfunction in daily life activities.

Entities:  

Keywords:  Adolescent; BDEFS-CA Long Form; children; executive functions; reliability; validity

Year:  2020        PMID: 32069127     DOI: 10.1080/21622965.2020.1726352

Source DB:  PubMed          Journal:  Appl Neuropsychol Child        ISSN: 2162-2965            Impact factor:   1.493


  1 in total

Review 1.  Assessment Tools for Executive Function and Adaptive Function Following Brain Pathology Among Children in Developing Country Contexts: a Scoping Review of Current Tools.

Authors:  Kwabena Kusi-Mensah; Nana Dansoah Nuamah; Stephen Wemakor; Joel Agorinya; Ramata Seidu; Charles Martyn-Dickens; Andrew Bateman
Journal:  Neuropsychol Rev       Date:  2021-12-06       Impact factor: 6.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.